Valuation: Bayer AG

Market Cap 47.24B 54.18B 44.61B 40.51B 75.9B 5,199B 76.21B 534B 206B 2,643B 204B 199B 8,505B P/E 2026 *
21.8x
P/E 2027 * 15.7x
Enterprise Value 77.2B 88.53B 72.89B 66.19B 124B 8,495B 125B 873B 337B 4,319B 333B 325B 13,896B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.58x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.16%
1 week-3.45%
Current month+0.90%
1 month+1.77%
3 months+33.54%
6 months+24.96%
Current year+37.99%
1 week 212.4
Extreme 212.4
220
1 month 206.7
Extreme 206.7
220
3 years 78.97
Extreme 78.97
231.65
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.45%+80.34%-8.31% 54.18B
+0.04%+3.34%+53.32%+102.40% 1,028B
-0.09%+1.66%+53.24%+65.73% 651B
-0.02%+2.66%+18.65%+71.84% 466B
+0.25%-1.08%+31.87%+42.40% 346B
+0.28%+1.39%+17.50%+24.58% 266B
-0.85%+2.21%+8.02%+14.11% 259B
+1.55%+2.20%+35.12%+42.07% 208B
-0.91%-0.32%-27.06%-56.48% 191B
-0.52%+4.45%+31.57%+97.98% 186B
Average -0.02%+3.26%+30.26%+39.63% 400.19B
Weighted average by Cap. -0.00%+3.09%+35.09%+60.76%

Financials

2026 *2027 *
Net sales 45.77B 52.49B 43.22B 39.25B 73.53B 5,037B 73.84B 518B 200B 2,561B 197B 193B 8,239B 46.99B 53.88B 44.37B 40.29B 75.48B 5,170B 75.8B 531B 205B 2,629B 202B 198B 8,458B
Net income 2.14B 2.46B 2.02B 1.84B 3.44B 236B 3.45B 24.21B 9.34B 120B 9.22B 9.02B 385B 2.94B 3.37B 2.77B 2.52B 4.72B 323B 4.74B 33.23B 12.82B 164B 12.65B 12.37B 529B
Net Debt 29.95B 34.35B 28.28B 25.68B 48.12B 3,296B 48.32B 339B 131B 1,676B 129B 126B 5,392B 26.82B 30.76B 25.33B 23B 43.09B 2,952B 43.27B 303B 117B 1,501B 116B 113B 4,829B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
18/09/26 PLN 212.40 0.00%
17/09/26 PLN 212.40 0.00%
16/09/26 PLN 212.40 -3.28%
15/09/26 PLN 219.60 -0.18%
14/09/26 PLN 220.00 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.09EUR
Average target price
58.22EUR
Spread / Average Target
+21.07%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!